Page last updated: 2024-12-05
acid orange 12
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
acid orange 12: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 135465070 |
CHEMBL ID | 2028361 |
SCHEMBL ID | 2865909 |
SCHEMBL ID | 755171 |
SCHEMBL ID | 9343017 |
MeSH ID | M0054656 |
Synonyms (36)
Synonym |
---|
ponceau 4g |
1934-20-9 |
nsc 7831 |
1-phenylazo-2-naphthol-6-sulphonic acid monosodium salt |
einecs 217-697-4 |
crocein orange g |
sodium 6-hydroxy-5-phenylazo-2-naphthalenesulphonate |
6-hydroxy-5-(phenylazo)-2-naphthalenesulfonic acid, sodium salt |
2-naphthalenesulfonic acid, 6-hydroxy-5-(phenylazo)-, monosodium salt |
acid orange 12 |
ccris 7443 |
unii-i3d360r468 |
2-naphthalenesulfonic acid, 6-hydroxy-5-(2-phenyldiazenyl)-, sodium salt (1:1) |
i3d360r468 , |
AKOS024319597 |
AKOS015889969 |
SCHEMBL2865909 |
ci 15970 |
sodium 1-(phenylazo)-2-naphthol-6-sulfonate |
DTXSID9062069 |
SCHEMBL755171 |
CHEMBL2028361 |
SCHEMBL9343017 |
mfcd00003912 |
sodium 6-hydroxy-5-[(e)-phenyldiazenyl]-2-naphthalenesulfonate |
J-012523 |
sodium (e)-6-hydroxy-5-(phenyldiazenyl)naphthalene-2-sulfonate |
6-hydroxy-5-(phenylazo)-2-naphthalenesulfonic acid monosodium salt |
acidorange12dye |
Q27280314 |
D89333 |
2-naphthalenesulfonicacid,6-hydroxy-5-(2-phenyldiazenyl)-,sodium salt(1:1) |
sodium 6-hydroxy-5-(phenyldiazenyl)naphthalene-2-sulfonate |
sodium;6-hydroxy-5-phenyldiazenylnaphthalene-2-sulfonate |
sodium 6-hydroxy-5-[(1e)-2-phenyldiazen-1-yl]naphthalene-2-sulfonate |
CS-0213841 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (10.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (90.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |